Table 2.
CITED2 involvement in disease states.
Disease states | CITED2 relevance | References |
---|---|---|
Glucose homeostasis and diabetes | Required for the regulation of hepatic gluconeogenesis | [50,156] |
Downregulation mediates high glucose-induced endoplasmic reticulum stress-dependent apoptosis | [51] | |
Upregulated in vascular tissue of patients with obesity and type 2 diabetes | [157] | |
Impairs insulin signaling in endothelial cells | [158] | |
Decreased in heart tissue of maternal diabetic-exposed embryos | [58] | |
Increased expression in adipose-derived stem cells from diabetic patients, which exhibit decreased proliferation and wound healing abilities | [159] | |
Inflammation | Potent repressor of macrophage proinflammatory activation | [23] |
Myeloid deficiency significantly increases macrophage and neutrophil recruitment | [32] | |
Restrains signal transducer and activator of transcription 1 (STAT1) and interferon regulatory factor 1 (IRF1) signaling in macrophages and limits development of atherosclerotic plaques | [73] | |
Deficiency results in enhanced placenta interferon-responsive gene expression | [44] | |
Pregnancy related disorders | Lower levels in cumulus cells are associated with higher rates of oocyte fertilization and embryo implantation | [161] |
Dysregulated in the placenta from mothers with hypertension | [160] | |
Upregulated in placentas from women with severe preeclampsia | [61] | |
Upregulated in placentas from growth restricted fetuses | [87] | |
Decreased expression in endoplasmic-reticulum stress-induced BeWo choriocarcinoma cells (note: CITED2 may be restricted to the transformed character of the cells and not their trophoblast origin) | [62] | |
Cardiovascular disease | Essential for heart development | [20,21,26,27,44,162] |
Mutations contribute to congenital heart disease | [24,28-30,52-57] | |
Lung development | Dysregulation results in aberrations in lung development | [44,163,164] |
Neurodevelopmental disorders | Deficiency results in an abnormal neural development (exencephaly) in the mouse, a phenotype reduced with folic acid treatment | [4,21,40] |